← Eichor
Study identifier: NCT06259006 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children

Condition: Rheumatic Fever · Sydenham Chorea  ·  Sponsor: Starship Child Health, Te Toka Tumai Auckland

PhasePhase 3
Planned participants80
Who can joinAll sexes, 4 Years to 17 Years
Healthy volunteersNo

About this study

The purpose of this study is to find out whether an early three-day course of an oral steroid medication (dexamethasone) can improve the physical and mental recovery and wellbeing for children with Sydenham's chorea. Sydenham's chorea is a condition that impacts approximately 12% of children with acute rheumatic fever. It is caused by inflammation in the brain following an abnormal immune response to Group A streptococcus bacterial infection. Sydenham's chorea is a movement disorder that causes children's faces, hands, and feet to move quickly and uncontrollably, and can also affect mood and concentration. The physical recovery from Sydenham's chorea can take two to six months but the mental recovery (e.g. mood and concentration) can take longer to resolve. Sydenham's chorea remains endemic in Māori, Pacific Islander, Aboriginal and Torres Strait Islander children in New Zealand and Australia. There is limited evidence to direct treatment of Sydenham's chorea, and clinical practice differs widely around the world. Dexamethasone is an oral steroid which targets the abnormal immune response and successfully treats other immune-mediated brain disorders, with good tolerability. TREAT-SC is a randomized, double-blinded, placebo-controlled trial which will investigate whether a three day course of oral dexamethasone safely and effectively treats the movement disorder and psychiatric symptoms of Sydenham's chorea. The trial will recruit 80 participants from study sites in Austral…

This description comes directly from the study's public registry record.

Talk to the study team

Hannah F Jones, MBChB PhD  ·  +64 9 307 4949  ·  hannahj1@adhb.govt.nz

Starship Research Office  ·  +64 21 369 340  ·  starshipresearch@adhb.govt.nz

Always discuss trial participation with your own doctor first.

Locations (17)

Royal Darwin HospitalDarwin, Northern Territories, AustraliaRecruiting
KidzFirst HospitalAuckland, New ZealandRecruiting
Starship Child Health, Te Toka Tumai, AucklandAuckland, New ZealandRecruiting
Waitākere HospitalAuckland, New ZealandRecruiting
Gisborne HospitalGisborne, New ZealandRecruiting
Waikato HospitalHamilton, New ZealandRecruiting
Hawkes Bay Fallen Soldiers' Memorial HospitalHastings, New ZealandRecruiting
Hutt HospitalLower Hutt, New ZealandRecruiting
Wairarapa HospitalMasterton, New ZealandRecruiting
Taranaki Base HospitalNew Plymouth, New ZealandRecruiting
Palmerston North HospitalPalmerston North, New ZealandRecruiting
Rotorua HospitalRotorua, New ZealandRecruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06259006